Circulating levels of anti-inflammatory cytokines that induce immunoparesis, such as IL-10 (IL-10) and IL-1 receptor antagonist, are markedly raised in patients with AD and more so in those with ACLF (74). This evidence concerns the gene IL10 and Alzheimer disease.